Cargando…
Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice
Professional antigen-presenting cells, such as dendritic cells, macrophages and B cells have been implicated in the pathogenesis of rheumatoid arthritis, constituting a possible target for antigen-specific immunotherapy. We addressed the possibility of blocking antigen presentation of the type II co...
Autores principales: | von Delwig, Alexei, Hilkens, Catharien MU, Altmann, Daniel M, Holmdahl, Rikard, Isaacs, John D, Harding, Clifford V, Robertson, Helen, McKie, Norman, Robinson, John H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779380/ https://www.ncbi.nlm.nih.gov/pubmed/16704744 http://dx.doi.org/10.1186/ar1964 |
Ejemplares similares
-
Human type II collagen is processed in lysosomal compartments of macrophages for presentation of the glycosylated arthritogenic epitope hCII(259–273 )to CD4 T cells in HLA-DR1 transgenic mice
por: von Delwig, A, et al.
Publicado: (2005) -
Specificity of CD4 T-cell responses to aggrecan in BALB/c and DR1 transgenic mice
por: Lowes, K, et al.
Publicado: (2005) -
An HLA-DR1 Transgene Confers Susceptibility to Collagen-induced Arthritis Elicited with Human Type II Collagen
por: Rosloniec, Edward F., et al.
Publicado: (1997) -
LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells
por: Anderson, Amy E., et al.
Publicado: (2009) -
Generation of dexamethasone and vitamin D3-treated human monocyte-derived dendritic cells with tolerogenic properties
por: Sayers, Bethan, et al.
Publicado: (2007)